Efficacy of Tasimelteon (HETLIOZ®) in the Treatment of Jet Lag Disorder Evaluated in an 8-h Phase Advance Model; a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Overview of attention for article published in Frontiers in Neurology, July 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 12 news stories from 12 outlets.

WASHINGTON, Aug. 5, 2020 /PRNewswire/ -- Vanda Pharmaceuticals, Inc. (Vanda) (Nasdaq: ) today announced financial and…

- Q2 2020 Total net product sales reached a new record of $62.2 million, a 7% increase as compared to Q1 2020 - Q2 2020 HETLIOZ®…

, at 4:30 PM ET. are very proud of the achievements of our team, especially the record commercial performance, even in the face…

- Q2 2020 Total net product sales reached a new record of $62.2 million, a 7% increase as compared to Q1 2020 - Q2 2020 HETLIOZ®…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 8 additional news stories.